Press Releases

CLEARWATER, Fla., Oct. 28, 2019 /PRNewswire/ -- Acacia Diversified Holdings, Inc. ("Acacia" or the "Company") (OTCQB: ACCA), www.acaciadiversifiedholdings

Read more...

JACKSONVILLE, Fla., Oct. 28, 2019 /PRNewswire/ -- In recognition of November's Diabetes Awareness Month, Healogics®, the nation's wound healing expert, is proud to participate in a national diabetes awareness campaign October 28 through November 1. This campaign aims to raise awareness of early intervention and specialized care for diabe

Read more...

New Partnership Aimed at Providing Personalized Diabetes Support and Management Program Paired with the Protection of Life Insurance and the Potential to Earn up to 25% in Premium SavingsTSX/NYSE/PSE: MFC, SEHK: 945 BOSTON, Oct. 28, 2019 /PRNewswire/ -

Read more...

LAS VEGAS, Oct. 28, 2019 /PRNewswire/ -- Greenery Map, the world's first and only cannabis search engine to allow users to search for cannabis products based on their desired mo

Read more...

SCOTTSDALE, Ariz., Oct. 28, 2019 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE: HTA) ("HTA") announced results for the three and nine months ended September 30, 2019.

Read more...

OVERLAND PARK, Kan., Oct. 28, 2019 /PRNewswire/ -- Rx Savings Solutions has developed a strategic relationship with

Read more...

CONCORD, Mass., Oct. 28, 2019 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation,

Read more...

DENVER, Oct. 28, 2019 /PRNewswire/ -- Rx Green Technologies, www.rxgreentechnologies.com, a leader in cannabis nutrients, substrates, and pest management has partnered with

Read more...

REDWOOD CITY, Calif., Oct. 28, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release third quarter financial results after market close on Wednesday, November 6, 2019. AcelRx management will host a live webcast and conference call at

Read more...

WASHINGTON, Oct. 28, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Anne Sempowski Ward has joined the company's Board of Directors, effective October 28, 2019. Following Ms. Ward's appointment, Vanda's Board of Directors is now comprised of six directors.

Read more...